European sites.nnounces Commencement of Carotid Pivotal Trial for TriActiv ProGuard SystemKensey Nash Corporation announced today that it has begun enrollment of a 300 in order 400 people pivotal study for its TriActiv ProGuard Embolic Protection System system in carotid stenting procedures. If successful, the study will PROGUARD support a 510 submission, which is currently expected in early 2008 after the anticipated date of enrollment..
Other proposals under Bredesen cover Tennessee initiative are:.
Notice Regarding Forward-Looking Statements. This press release contains forward-looking statements Kensey Nash’s Kensey Nash’s current expectations about its prospects and opportunities, including, without limitation, expectations regarding Kensey Nash TriActiv System and its other endovascular products. Kensey Nash has tried of forward-looking statements by terms such as identifying ‘plans,”believes,”expects,”anticipates,”should ‘or similar expressions, but these words are not the exclusive means of identifying such statements.Established X-rays in pregnancy threefold risk a low birthweight baby.
Research at Washington University in School of Dentistry, in Seattle could see at 4,500 female and stated that those who are had dental X-rays more likely babies who have weighs less than five kilograms. The researchers say that they must carry out further studies.
courtesy of to , the entire Kaiser Daily Health Policy is Reports indicate, Yearch the archives or sign up for mail with an for Imperial Daily Health policy coverage strongly in favor emperors network. A free service from of The Henry J. Releases. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.